For the first time, a CRISPR drug treats a child’s unique mutation
Title: Milestone Achievement: CRISPR Therapy Successfully Addresses Rare Genetic Mutation in Pediatric Patient
Subtitle: Researchers anticipate that this breakthrough will pave the way for broader therapeutic applications for young patients
Source: The Economist Generated at: 2025-05-15 17:00:00 UTC






